We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse.
- Authors
Walsh, Douglas S; Wilairatana, Polrat; Tang, Douglas B; Heppner, D Gray, Jr; Brewer, Thomas G; Krudsood, Srivicha; Silachamroon, Udomsak; Phumratanaprapin, Weerapong; Siriyanonda, Duangsuda; Looareesuwan, Sornchai
- Abstract
Tafenoquine is an 8-aminoquinoline developed as a more effective replacement for primaquine. In a previous dose-ranging study in Thailand, 3 tafenoquine regimens with total doses ranging from 500 mg to 3000 mg prevented relapse of Plasmodium vivax malaria in most patients when administered 2 days after receipt of a blood schizonticidal dose of chloroquine.
- Publication
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Vol 39, Issue 8, p1095
- ISSN
1537-6591
- Publication type
Journal Article
- DOI
10.1086/424508